Abstract
All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.
| Original language | English |
|---|---|
| Pages (from-to) | 199-208 |
| Number of pages | 10 |
| Journal | Gynecologic Oncology |
| Volume | 14 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 1982 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Oncology
Cite this
Carcinoma of the uterine cervix FIGO stage I-B. / Adcock, Leon L.; Julian, Thomas M.; Okagaki, Takashi; Jones, Thomas K.; Prem, Konald A.; Twiggs, Leo B.; Potish, Roger A.; Phillips, George L.
In: Gynecologic Oncology, Vol. 14, No. 2, 01.01.1982, p. 199-208.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Carcinoma of the uterine cervix FIGO stage I-B
AU - Adcock, Leon L.
AU - Julian, Thomas M.
AU - Okagaki, Takashi
AU - Jones, Thomas K.
AU - Prem, Konald A.
AU - Twiggs, Leo B.
AU - Potish, Roger A.
AU - Phillips, George L.
PY - 1982/1/1
Y1 - 1982/1/1
N2 - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.
AB - All patients with cervical carcinoma, FIGO Stage I-B, admitted to the Gynecologic Oncology Service of the University of Minnesota Hospitals during the 10-year period ending December 31, 1979, were reviewed. The 5-year survival rate without evidence of disease was 75.3%, the corrected rate being 80.8%. During the last half of the study there was a significant increase in the percentage of patients with adenosquamous carcinoma. The survival rate for younger patients with this diagnosis was significantly lower. Patients frequently had normally interpreted Pap smears in the years just prior to the diagnosis of invasive carcinoma. Early diagnosis of cervical carcinoma is essential. Reliance cannot be placed on a normally interpreted Pap smear, particularly for those patients who have adenosquamous carcinoma or adenocarcinoma.
UR - http://www.scopus.com/inward/record.url?scp=0019907058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019907058&partnerID=8YFLogxK
U2 - 10.1016/0090-8258(82)90090-7
DO - 10.1016/0090-8258(82)90090-7
M3 - Article
C2 - 7129216
AN - SCOPUS:0019907058
VL - 14
SP - 199
EP - 208
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 2
ER -